These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 36856154)
1. LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect malignant development of oral squamous cell carcinoma. Dong C; Zhao Y; Yang S; Jiao X J Oral Pathol Med; 2023 Jul; 52(6):493-503. PubMed ID: 36856154 [TBL] [Abstract][Full Text] [Related]
2. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells. Zhai J; Luo G Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888 [TBL] [Abstract][Full Text] [Related]
3. Tumor Promoting Role of NRIP1 in Oral Squamous Cell Carcinoma: The Involvement of NSD2-Mediated Histone Methylation of DGCR8. Zhang L; Hu G Tohoku J Exp Med; 2023 Jul; 260(3):193-204. PubMed ID: 37045786 [TBL] [Abstract][Full Text] [Related]
5. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression. Wang C; Wang Q; Weng Z Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069 [TBL] [Abstract][Full Text] [Related]
6. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway. Chen M; Zhang J J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis. Hei N; Chen Y; Peng S; Bao Y; Jin L Arch Oral Biol; 2022 Dec; 144():105567. PubMed ID: 36265392 [TBL] [Abstract][Full Text] [Related]
8. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p. Han L; Cheng J; Li A Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508 [No Abstract] [Full Text] [Related]
9. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3. He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147 [TBL] [Abstract][Full Text] [Related]
10. NSD2 activates the E2F transcription factor 1/Y-box binding protein 2 axis to promote the malignant development of oral squamous cell carcinoma. Zhang L; Hu G Arch Oral Biol; 2022 Jun; 138():105412. PubMed ID: 35364436 [TBL] [Abstract][Full Text] [Related]
11. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression. Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158 [TBL] [Abstract][Full Text] [Related]
12. CircLPAR3 Acts as an Oncogene in Oral Squamous Cell Carcinoma Through Regulating the miR-643/HMGB2 Network. Fu Y; Qiu C; Yang Y; Lu J; Qi Y Biochem Genet; 2022 Jun; 60(3):882-898. PubMed ID: 34528144 [TBL] [Abstract][Full Text] [Related]
13. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration. Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119744. PubMed ID: 38702016 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression. Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908 [TBL] [Abstract][Full Text] [Related]
15. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression. Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells. Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126 [TBL] [Abstract][Full Text] [Related]
17. MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2. Liu L; Guo B; Han Y; Xu S; Liu S Clin Transl Oncol; 2022 Jul; 24(7):1311-1321. PubMed ID: 35122633 [TBL] [Abstract][Full Text] [Related]
18. FUT8-AS1/miR-944/Fused in Sarcoma/Transcription Factor 4 Feedback Loop Participates in the Development of Oral Squamous Cell Carcinoma through Activation of Wnt/β-Catenin Signaling Pathway. Geng Z; Huang Y; Wu S; Zhu D; Li W Am J Pathol; 2023 Feb; 193(2):233-245. PubMed ID: 36697118 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma. Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670 [TBL] [Abstract][Full Text] [Related]
20. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2). Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]